Prospective registry of STEMI management in Covid era -INDIA (PRESCO-INDIA)
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 3,000
- 试验地点
- 1
- 主要终点
- To study the initial treatment strategy employed for hospitalized patients with STEMI in India during the current COVID-19 pandemic and to document the differences in the primary outcome of death, re-infarction and stroke in-hospital and at 30 days post discharge based on the initial treatment strategy.
研究概览
简要总结
This prospective study will helpto identify the initial treatment strategies employed during COVID-19 pandemicin India. The study will also evaluate the patient outcomes with lysis followedby a delayed PCI strategy often widely employed in India.Thedemographics, presentation patterns, major complications and in-hospitaloutcomes would be analysed. Multivariate analysis on factors leading to outcomeswill be carried out. Finally, the use of guidelines based medications in the countryin STEMI management would also be assessed. This is the first andlargest prospective study on STEMI on presentation and management of STEMI inIndia during COVID times and will provide insights into the STEMI management inthe country and the outcomes.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18.00 Year(s) 至 90.00 Year(s)（—）
- 性别
- All
入选标准
- •All consecutive patients above 18 years of age with STEMI as per 4thuniversal definition of MI during the study period.
排除标准
- •Patients below 18 years, Patients not willing to give informed consent, Patients with life-threatening diseases like severe COVID 19 infection on ventilator, Terminal malignancy, Debilitating stroke and CKD patients on maintenance haemodialysis, MI/PCI/CABG within past 14 days of STEMI admission, Patients thrombolysed elsewhere, Patients enrolled in any other research studies.
结局指标
主要结局
To study the initial treatment strategy employed for hospitalized patients with STEMI in India during the current COVID-19 pandemic and to document the differences in the primary outcome of death, re-infarction and stroke in-hospital and at 30 days post discharge based on the initial treatment strategy.
时间窗: 5 months or when target of 3000 patients are recruited which ever happens first
次要结局
- To evaluate the major in-hospital complications of STEMI patients in relation to the initial reperfusion strategy employed.(To study the differences in left ventricular function(LVEF) assessed by echocardiography during hospital admission and at 30 days post discharge among STEMI patients treated with various reperfusion strategies.)